Target Name: CD24
NCBI ID: G100133941
Review Report on CD24 Target / Biomarker Content of Review Report on CD24 Target / Biomarker
CD24
Other Name(s): Signal transducer CD24 (isoform a) | CD24 molecule | Small cell lung carcinoma cluster 4 antigen | CD24_HUMAN | CD24A | CD24 variant 1 | CD24 molecule, transcript variant 1 | Signal transducer CD24 | CD24 antigen (small cell lung carcinoma cluster 4 antigen)

CD24: A Drug Target / Disease Biomarker

CD24 is a protein that is expressed in the human immune system and is known for its role in the regulation of immune responses. It is a member of the immunoglobulin superfamily and is expressed in a variety of tissues throughout the body, including the skin, eyes, and nervous system. While CD24 has been identified as a potential drug target and biomarker for several diseases, its role in the immune system is still poorly understood.

CD24 is involved in the regulation of T cell development and function. It is a critical receptor for the antigens that stimulate the production of antibodies by T cells. CD24 helps to ensure that T cells are able to recognize and respond to foreign substances in the body. When a foreign substance, such as a virus or bacteria, enters the body, CD24 is involved in the process of its recognition and response. CD24 has been shown to play a key role in the development of autoimmune diseases, in which the immune system attacks the body's own tissues.

CD24 is also involved in the regulation of inflammation. It helps to control the production of pro-inflammatory cytokines, which are important mediators of inflammation. CD24 has been shown to play a key role in the regulation of inflammation in the immune system, and it has been proposed as a potential therapeutic target for diseases that are characterized by chronic inflammation, such as rheumatoid arthritis and inflammatory bowel disease.

CD24 has also been identified as a potential drug target for several diseases due to its role in the regulation of cell death. It is a critical receptor for the neurotransmitter PDGF-B, which is involved in the regulation of cell growth and differentiation. CD24 has been shown to play a key role in the regulation of cell death in the immune system, and it has been proposed as a potential therapeutic target for diseases that are characterized by the destruction of cells.

CD24 is also involved in the regulation of the immune response. It helps to ensure that immune cells are able to recognize and respond to foreign substances in the body. CD24 has been shown to play a key role in the regulation of the immune response in the skin, where it helps to ensure that immune cells are able to recognize and respond to foreign substances such as bacteria and viruses.

In conclusion, CD24 is a protein that is involved in the regulation of the immune system. It is a critical receptor for the antigens that stimulate the production of antibodies by T cells, and it plays a key role in the regulation of T cell development and function, inflammation, and cell death. While CD24 has been identified as a potential drug target and biomarker for several diseases, its role in the immune system is still poorly understood. Further research is needed to fully understand the role of CD24 in the immune system and its potential as a therapeutic target.

Protein Name: CD24 Molecule

Functions: May have a pivotal role in cell differentiation of different cell types. Signaling could be triggered by the binding of a lectin-like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Modulates B-cell activation responses. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells (PubMed:11313396). In association with SIGLEC10 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90. Plays a role in the control of autoimmunity (By similarity)

The "CD24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG